Table 2.
Distribution of Nectin-4 in esophageal cancer and patient clinicopathological characteristics.
Characteristic | Number of patients | Nectin-4 expression | χ2 | P-value | |
---|---|---|---|---|---|
Nectin-4 negative | Nectin-4 positive | ||||
Age (years) | 0.004 | 0.951 | |||
<60 | 23 | 6 | 17 | ||
≥60 | 59 | 15 | 44 | ||
Gender | |||||
Male | 62 | 17 | 45 | 0.437 | 0.509# |
Female | 20 | 4 | 16 | ||
Tumor size (cm) | |||||
<4.5 | 43 | 16 | 27 | 6.385 | 0.012* |
≥4.5 | 39 | 5 | 34 | ||
AJCC stage | |||||
I–II | 45 | 11 | 32 | 0.021 | 0.884 |
III–IV | 37 | 10 | 27 | ||
Tumor invasion (T stage) | |||||
T1/T2 | 19 | 9 | 10 | 7.081 | 0.008* |
T3/T4 | 63 | 11 | 52 | ||
Lymph node metastasis | |||||
Absent | 44 | 12 | 32 | 0.095 | 0.922 |
Present | 38 | 10 | 28 |
AJCC – American Joint Committee on Cancer. Values were analyzed using the chi-squared (χ2) test or Fisher’s exact test.
Incomplete data were removed.
P<0.05.